FDA Denies Accelerated Approval Path For Moderna & Merck's AI-Driven Melanoma Vaccine

FDA declined accelerated approval for Moderna and Merck’s mRNA-4157 melanoma vaccine, citing challenges in reviewing AI-developed drugs, despite ongoing discussions.